| Literature DB >> 32713951 |
Horacio Márquez-González1, Daniel Ibarra Ríos2, María G Jean Tron1, Leticia A Barajas-Nava3.
Abstract
Pulmonary arterial hypertension is a multifactorial nosological entity that increases neonatal mortality as a result of heart failure. Pulmonary vasodilators are the cornerstone of treatment, of which sildenafil is the most commonly used drug. Therefore, the results of a recently updated Cochrane systematic review are summarized, in which the efficacy and safety of sildenafil for the treatment of pulmonary hypertension in neonates was evaluated. Copyright:Entities:
Keywords: Hipertensión arterial pulmonar; Mortalidad; Mortality; Neonato; Newborn; Pulmonary arterial hypertension; Revisión sistemática; Sildenafil; Systematic review
Year: 2020 PMID： 32713951 DOI： 10.24875/BMHIM.20000041
Source DB: PubMed Journal: Bol Med Hosp Infant Mex ISSN： 0539-6115